These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 36313905)

  • 1. Verification and Comparison of Qualitative Serological Assays for Anti-SARS-COV-2 IgM and IgG Antibodies Detection.
    Štebih M; Skitek M; Jerin A
    EJIFCC; 2022 Aug; 33(2):145-158. PubMed ID: 36313905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analytical and Clinical Analysis of Two Automated Anti-SARS-CoV-2 Immunoassays in Pre-Pandemic and Pandemic Patient Populations.
    Yang J; Pederson EC; Hamilton C; Neibauer T; Robyak K; McGhee P; Speicher T; Zhu Y
    J Appl Lab Med; 2021 Mar; 6(2):441-450. PubMed ID: 33152084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role and diagnostic accuracy of serology for COVID-19.
    Kundu D; Gautam P; Dayanand D; Gunasekaran K; Manesh A; Sebastian M; Abhilash KPP; Zachariah A; George T; Sathyendra S; Hansdak SG; Abraham OC; Iyadurai R; Thangakunam B; Gupta R; Karthik R; Moorthy M; Varghese GM
    BMC Infect Dis; 2022 Apr; 22(1):390. PubMed ID: 35439957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the Clinical Performances of the Abbott Alinity IgG, Abbott Architect IgM, and Roche Elecsys Total SARS-CoV-2 Antibody Assays.
    Harley K; Gunsolus IL
    J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 33106364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 Antibody Testing in Health Care Workers: A Comparison of the Clinical Performance of Three Commercially Available Antibody Assays.
    Allen N; Brady M; Carrion Martin AI; Domegan L; Walsh C; Houlihan E; Kerr C; Doherty L; King J; Doheny M; Griffin D; Molloy M; Dunne J; Crowley V; Holmes P; Keogh E; Naughton S; Kelly M; O'Rourke F; Lynagh Y; Crowley B; de Gascun C; Holder P; Bergin C; Fleming C; Ni Riain U; Conlon N;
    Microbiol Spectr; 2021 Oct; 9(2):e0039121. PubMed ID: 34585976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serological Assays for Assessing Postvaccination SARS-CoV-2 Antibody Response.
    Mahmoud SA; Ganesan S; Naik S; Bissar S; Zamel IA; Warren KN; Zaher WA; Khan G
    Microbiol Spectr; 2021 Oct; 9(2):e0073321. PubMed ID: 34585943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of the FREND™ COVID-19 IgG/IgM Duo point-of-care test for SARS-CoV-2 antibody detection.
    De Munck DG; Peeters B; Huyghe E; Goossens H; Ieven M; Matheeussen V
    Acta Clin Belg; 2022 Jun; 77(3):647-652. PubMed ID: 34152943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-SARS-CoV-2 IgM improves clinical sensitivity early in disease course.
    Higgins V; Fabros A; Wang XY; Bhandari M; Daghfal DJ; Kulasingam V
    Clin Biochem; 2021 Apr; 90():1-7. PubMed ID: 33476578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specificity testing by point prevalence as a simple assessment strategy using the Roche Elecsys® anti-SARS-CoV-2 immunoassay.
    Kittel M; Findeisen P; Muth MC; Thiaucourt M; Gerhards C; Neumaier M; Haselmann V
    Int J Infect Dis; 2021 Apr; 105():632-638. PubMed ID: 33578017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the Elecsys® Anti-SARS-CoV-2 immunoassay with the EDI™ enzyme linked immunosorbent assays for the detection of SARS-CoV-2 antibodies in human plasma.
    Egger M; Bundschuh C; Wiesinger K; Gabriel C; Clodi M; Mueller T; Dieplinger B
    Clin Chim Acta; 2020 Oct; 509():18-21. PubMed ID: 32485155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of time on the sensitivity of SARS-CoV-2 serological testing.
    Torres Ortiz A; Fenn Torrente F; Twigg A; Hatcher J; Saso A; Lam T; Johnson M; Wagstaffe H; Dhillon R; Mai AL; Goldblatt D; Still R; Buckland M; Gilmour K; Grandjean L
    Sci Rep; 2022 Jun; 12(1):10517. PubMed ID: 35732870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent Advances in the Evaluation of Serological Assays for the Diagnosis of SARS-CoV-2 Infection and COVID-19.
    Chiereghin A; Zagari RM; Galli S; Moroni A; Gabrielli L; Venturoli S; Bon I; Rossini G; Saracino IM; Pavoni M; Lafratta S; Deni A; Felici S; Borghi M; Guerra L; Raumer L; Lodi V; Viale P; Attard L; Lazzarotto T;
    Front Public Health; 2020; 8():620222. PubMed ID: 33681115
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative study of six SARS-CoV-2 serology assays: Diagnostic performance and antibody dynamics in a cohort of hospitalized patients for moderate to critical COVID-19.
    Chamkhi S; Dhaouadi T; Sfar I; Mokni S; Jebri A; Mansouri D; Ghedira S; Ben Jemia E; Ben Boujemaa S; Houissa M; Aouina H; Ben Abdallah T; Gorgi Y
    Int J Immunopathol Pharmacol; 2022; 36():20587384211073232. PubMed ID: 35113728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of two rapid point of care SARS-COV-2 antibody assays against laboratory-based automated chemiluminescent immunoassays for SARS-COV-2 IG-G, IG-M and total antibodies.
    Lau CS; Hoo SP; Liang YL; Phua SK; Aw TC
    Pract Lab Med; 2021 Mar; 24():e00201. PubMed ID: 33501369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and analytical evaluation of the Abbott AdviseDx quantitative SARS-CoV-2 IgG assay and comparison with two other serological tests.
    Maine GN; Krishnan SM; Walewski K; Trueman J; Sykes E; Sun Q
    J Immunol Methods; 2022 Apr; 503():113243. PubMed ID: 35181288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Head-to-head comparison of two rapid high-throughput automated electrochemiluminescence immunoassays targeting total antibodies to the SARS-CoV-2 nucleoprotein and spike protein receptor binding domain.
    Poljak M; Oštrbenk Valenčak A; Štamol T; Seme K
    J Clin Virol; 2021 Apr; 137():104784. PubMed ID: 33711693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analytical and Clinical Evaluation of the Automated Elecsys Anti-SARS-CoV-2 Antibody Assay on the Roche cobas e602 Analyzer.
    Chan CW; Parker K; Tesic V; Baldwin A; Tang NY; van Wijk XMR; Yeo KJ
    Am J Clin Pathol; 2020 Oct; 154(5):620-626. PubMed ID: 32814955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of the Roche/Snibe electrochemiluminescent anti-SARS-COV-2 spike assays compared to the Roche/Abbott IgG nucleocapsid and Abbott IgM spike assays.
    Lau CS; Wong MS; Hoo SP; Heng PY; Phua SK; Aw TC
    Pract Lab Med; 2021 Nov; 27():e00257. PubMed ID: 34660869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid and Laboratory SARS-CoV-2 Antibody Testing in High-Risk Hospital Associated Cohorts of Unknown COVID-19 Exposure, a Validation and Epidemiological Study After the First Wave of the Pandemic.
    O'Kelly B; McLaughlin R; O'Doherty R; Carroll H; Murray R; Dilworth R; Corkery L; Cotter AG; McGinty T; Muldoon EG; Cullen W; Avramovic G; Sheehan G; Sadlier D; Higgins M; O'Gorman P; Doran P; Inzitari R; Holden S; O'Meara Y; Ennis S; Lambert JS
    Front Med (Lausanne); 2021; 8():642318. PubMed ID: 34513853
    [No Abstract]   [Full Text] [Related]  

  • 20. Performance characteristics of five SARS-CoV-2 serological assays: Clinical utility in health-care workers.
    Heffernan E; Kennedy L; Hannan MM; Ramlaul N; Denieffe S; Courtney G; Watt A; Hurley J; Lynch M; Fitzgibbon M
    Ann Clin Biochem; 2021 Sep; 58(5):496-504. PubMed ID: 33845592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.